SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Redemption of Notes

13 Jan 2023 10:52

RNS Number : 6842M
Nationwide Building Society
13 January 2023
 

NATIONWIDE BUILDING SOCIETY*

(the Society)

NOTICE

to the holders of the

$1,000,000,000 aggregate principal amount of Fixed-to-Floating Notes due 2024 issued by the Society

(ISINs:

US63861VAA52,

US63861WAA36)

(the Notes)

NOTICE IS HEREBY GIVEN by the Society to the holders of the Notes that, having obtained Relevant Supervisory Consent from the Prudential Regulation Authority in accordance with the Section "Preconditions to Redemption, Purchase, Substitution or Variation of Notes" of the Notes, the Society will redeem the Notes in full on 8 March 2023 pursuant to the Section "Redemption at the Issuer's Option" of the Notes.

The Notes will be redeemed at their principal amount, together with unpaid interest accrued to (but excluding) the repayment date.

Following redemption of the Notes, (i) the Notes will be cancelled and no further interest payments will be made and (ii) request will be made to the Financial Conduct Authority (the FCA) for the listing of the Notes on the Official List of the FCA and the admission to trading on the regulated market of the London Stock Exchange to be cancelled.

All capitalized terms used herein and not defined shall have the meanings assigned to such terms in the Notes.

For further information, please contact:

 

Sarah Abercrombie

Head of Investor Relations and Credit Ratings

 

Telephone: +44 (0) 7587 886500

Email: Sarah.Abercrombie@nationwide.co.uk

 

Nationwide Building Society

Nationwide House

Pipers Way

Swindon SN38 1NW

England

 

* LEI: 549300XFX12G42QIKN82

Dated: 13 January 2023

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFLFSILDIVLIV
Date   Source Headline
12th Jun 20262:02 pmRNSPublication of a Prospectus
12th Jun 202611:31 amRNSPublication of Registration Document
12th Jun 202611:24 amRNSPublication of a Prospectus
9th Jun 202611:15 amRNSAdmission to Trading
8th Jun 202611:52 amRNSNOTICE TO NOTEHOLDERS
5th Jun 20262:58 pmRNSPublication of Final Terms
21st May 202612:33 pmRNSPublication of a Supplementary Prospectus
21st May 20267:00 amRNSPreliminary Results Announcement
6th May 20263:12 pmRNSPublication of Final Terms
21st Apr 20263:38 pmRNSPublication of Final Terms
21st Apr 202610:20 amRNSCancellation of Listing
20th Apr 202612:38 pmRNSNotice to Covered Bondholders
9th Apr 202611:06 amRNSPublication of a Supplementary Prospectus
7th Apr 20267:00 amRNSPart VII Transfer & Board changes
20th Mar 20268:48 amRNSRedemption of Securities
3rd Mar 202611:50 amRNSAdmission to Trading
3rd Mar 202611:44 amRNSAdmission to Trading
27th Feb 20265:18 pmRNSPublication of Final Terms
27th Feb 20263:56 pmRNSPublication of Final Terms
26th Feb 202611:00 amRNSPart VII Transfer
24th Feb 20269:51 amRNSAdmission to Trading
20th Feb 20269:47 amRNSPublication of Final Terms
19th Feb 202610:04 amRNSAdmission to Trading
17th Feb 20269:56 amRNSAdmission to Trading
17th Feb 20269:46 amRNSPublication of Final Terms
13th Feb 20262:04 pmRNSPublication of Final Terms
13th Feb 20268:15 amRNSPost Stabilisation Notice
3rd Feb 20262:41 pmRNSAdmission to Trading
30th Jan 20261:00 pmRNSPublication of Final Terms
16th Jan 20261:21 pmRNSPublication of Final Terms
8th Jan 20261:49 pmRNSPublication of Final Terms
8th Jan 20267:00 amRNSDirectorate change
7th Jan 202610:49 amRNSPre Stabilisation Notice
19th Dec 202511:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirectorate change
16th Dec 20252:42 pmRNSPublication of a Supplementary Prospectus
2nd Dec 20257:10 amRNSResponse to 2025 BOE Capital Stress Test Results
2nd Dec 20257:00 amRNSRevocation of Sub-consolidation Direction
20th Nov 202511:47 amRNSPublication of Supplement
20th Nov 20257:00 amRNSInterim Results September 2025
14th Nov 202511:00 amRNSPart VII Transfer
21st Oct 20251:08 pmRNSPublication of Final Terms
10th Oct 202512:52 pmRNSPublication of Final Terms
1st Oct 20257:00 amRNSConfirmation of Post-Offer Intention Statements
30th Sep 202510:03 amRNSBoard Changes
30th Sep 20259:43 amRNSBoard Changes
30th Sep 20257:00 amRNSBoard Changes
26th Sep 20252:49 pmRNSPublication of Final Terms
16th Sep 20251:48 pmRNSPublication of Final Terms
8th Sep 202511:27 amRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.